CiteFacts · FDA Drug Shortages · FDA source
Rocuronium Bromide Injection
Status
FDA currently lists this ingredient in shortage.
This is nationwide FDA status, not local pharmacy inventory. CiteFacts does not provide medical, treatment, substitution, or dosing advice.
FDA package and manufacturer records
| Company | Presentation | FDA availability field | FDA update |
|---|---|---|---|
| Baxter Healthcare | Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 43066-013-10) | Available | 08/17/2026 |
| Baxter Healthcare | Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 43066-007-10) | Available | 08/17/2026 |
| Eugia US LLC | Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 55150-226-10) | Available | 08/06/2026 |
| Eugia US LLC | Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 55150-225-05) | Available | 08/06/2026 |
| Fresenius Kabi USA, LLC | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 63323-426-05) | Available | 08/04/2026 |
| Fresenius Kabi USA, LLC | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 63323-426-10) | Available | 08/04/2026 |
| Fresenius Kabi USA, LLC | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-065-05) | Unavailable | 08/04/2026 |
| Fresenius Kabi USA, LLC | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-442-05) | Available | 08/04/2026 |
| Fresenius Kabi USA, LLC | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-444-10) | Available | 08/04/2026 |
| Hikma Pharmaceuticals USA, Inc. | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0143-9250-10) | Available | 08/13/2026 |
| Hikma Pharmaceuticals USA, Inc. | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0143-9251-10) | Available | 08/13/2026 |
| Hospira, Inc., a Pfizer Company | Rocuronium Bromide, Injection, 100 mg/10 mL (10 mg/mL) (NDC 0409-5160-10) | Available | 08/07/2026 |
| Hospira, Inc., a Pfizer Company | Rocuronium Bromide, Injection, 100 mg/10 mL (10 mg/mL) (NDC 0409-7037-10) | Available | 08/07/2026 |
| Hospira, Inc., a Pfizer Company | Rocuronium Bromide, Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-1403-10) | Available | 08/07/2026 |
| Hospira, Inc., a Pfizer Company | Rocuronium Bromide, Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-3189-10) | Available | 08/07/2026 |
| Meitheal Pharmaceuticals, Inc. | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 71288-700-06) | Available | 06/01/2026 |
| Meitheal Pharmaceuticals, Inc. | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 71288-718-11) | Available | 06/01/2026 |
| Mylan Institutional, a Viatris Company | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 67457-228-05) | Available | 08/20/2026 |
| Mylan Institutional, a Viatris Company | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 67457-228-10) | Available | 08/20/2026 |
| Piramal Critical Care Inc. | Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 66794-229-41) | Limited Availability | 08/04/2026 |
| Piramal Critical Care Inc. | Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 66794-228-41) | Limited Availability | 08/04/2026 |
| Sagent Pharmaceuticals | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 25021-687-05) | Available | 08/18/2026 |
| Sandoz Inc. | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0781-3220-92) | Available | 08/18/2026 |
| Sandoz Inc. | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0781-3220-95) | Available | 08/18/2026 |
| XGen Pharmaceuticals DJB, Inc. | Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 39822-4200-6) | Available | 08/17/2026 |
| XGen Pharmaceuticals DJB, Inc. | Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 39822-4200-2) | Available | 08/17/2026 |
Source facts
Grouped generic ingredient: Rocuronium Bromide Injection · 26 package records · Latest FDA row update: 08/20/2026
Therapeutic categories: Anesthesia
Dosage forms: Injection
Routes: INTRAVENOUS
Open FDA source data · JSON · Markdown
FDA is authoritative. Source retrieved 2026-08-22T15:54:11+00:00. Derived grouping is documented in this record's derivations.